Ownership history in Deep Track Capital, LP · 11 quarters on record
This page tracks every 13F SEC filing in which Deep Track Capital, LP reported a position in ANI PHARMACEUTICALS INC (ANIP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 477,684 | +27,684 | +6.2% | 0.67% | $37.7M | $78.94 |
| 2025 Q3 | REDUCED | 450,000 | -250,000 | -35.7% | 1.15% | $41.2M | $91.60 |
| 2025 Q2 | UNCHANGED | 700,000 | — | 0% | 1.46% | $45.7M | $65.25 |
| 2025 Q1 | ADDED | 700,000 | +50,958 | +7.9% | 1.52% | $46.9M | $66.95 |
| 2024 Q4 | ADDED | 649,042 | +144,214 | +28.6% | 1.34% | $35.9M | $55.28 |
| 2024 Q3 | ADDED | 504,828 | +38,739 | +8.3% | 0.96% | $30.1M | $59.66 |
| 2024 Q2 | REDUCED | 466,089 | -355,912 | -43.3% | 0.89% | $29.7M | $63.68 |
| 2024 Q1 | ADDED | 822,001 | +222,001 | +37.0% | 1.63% | $56.8M | $69.13 |
| 2023 Q4 | ADDED | 600,000 | +200,000 | +50.0% | 1.10% | $33.1M | $55.14 |
| 2023 Q3 | REDUCED | 400,000 | -114,021 | -22.2% | 0.90% | $23.2M | $58.06 |
As of 2025 Q4 — sorted by position size